As part of our commitment to transparency, we regularly report on our quality performance results, cost-sharing data, and organizational makeup.
ACO Name and Location
Adirondacks ACO, LLC
Previous Names: N/A
75 Beekman Street
Plattsburgh, NY 12901
ACO Primary Contact
Karen L. Ashline
(518)314-3663
kashline@cvph.org
Organizational Information
ACO participants:
ACO Participants | ACO Participant in Joint Venture |
North Wind Primary Care PLLC | N |
Kristin Ambler, MD | N |
Russell Rider | N |
Glens Falls Hospital, Inc. | N |
Champlain Valley Physicians | N |
Elizabethtown Community Hospital | N |
Hudson Headwaters Health Network | N |
Adirondack Medical Center | N |
Citizen Advocates | N |
Irongate Family Practice Associates, PLLC | N |
Alice Hyde Medical Center | N |
Behavioral Health Services North | N |
Plattsburgh Medical Care, PLLC | N |
Adirondack Medical Practice, LLC | N |
Lake City Primary Care, PLLC | N |
ACO Governing Body:
Member Last Name | Member First Name | Member Title/Position | Member’s Voting Power: expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name/DBA, if applicable |
Gallagher | Kevin | MD | 1 | ACO Participant Representative | Hudson Headwaters Health Network |
Tournier | Chris | CFO | 1 | ACO Participant Representative | Hudson Headwaters Health Network |
Scalise | Diana | SVP | 1 | ACO Participant Representative | University of Vermont Health Network CVPH |
Hickey | Chris | CFO | 1 | ACO Participant Representative | University of Vermont Health Network CVPH |
Beguin | David | MD | 1 | Pediatric Representative | Primary Care Health Partner |
Ambler | Kristin | MD | 1 | ACO Participant Representative | Kristin Ambler. MD |
Hatch | Ann Marie | Sr. Director | 1 | ACO Participant Representative | Glens Falls Hospital, Inc. |
Letourneau | Craig | Controller | 1 | ACO Participant Representative | Glens Falls Hospital, Inc. |
Laba | Robert | CFO | 1 | ACO Participant Representative | Adirondack Medical Center |
Beiras | Darci | MD | 1 | ACO Participant Representative | Adirondack Medical Center |
Filion | Paul | MD | 1 | ACO Participant Representative | Irongate Family Practice Associates, PLLC |
Mannix | Martin | Retiree | 1 | Medicare Beneficiary Representative | NA |
Bulris-Allen | Amanda | Executive Director NAMI | 1 | Medicare Beneficiary Representative | NA |
Barker | Tess | CEO PPNNY | 1 | Represents Uninsured | NA |
Rietsema | Wouter | MD | 1 | ACO Participant Representative AHI Member | University of Vermont Health Network CVPH |
Key ACO Clinical and Administrative Leadership:
ACO Executive: Eric Burton
Medical Director: Wouter Rietsema
Compliance Officer: Justin Frazer
Quality Assurance/Improvement Officer: Wouter Rietsema
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name and Position |
Population Health Advisory | Wouter Rietsema, MD Chair |
Finance | Chris Tournier, Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
- Critical Access Hospital (CAH) billing under Method II
- Federally Qualified Health Center (FQHC)
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses:
- Third Agreement Period
- Performance Year 2020, $3,062,968
- Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $0
- First Agreement Period
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $0
Shared Savings Distribution:
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 2%
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: 98%
- Performance Year 2020
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2019
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2016
Quality Performance Results
2020 Quality Performance Results:
ACO # | Measure Name | Rate | ACO Mean |
ACO-38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions | 53.68 | 49.50 |
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 0.92 | 0.95 |
ACO-13 | Falls: Screening for Future Fall Risk | 77.15 | 84.97 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 77.56 | 76.03 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 82.43 | 81.67 |
ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 74.64 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 76.27 | 72.59 |
ACO-20 | Breast Cancer Screening | 77.84 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 86.02 | 83.37 |
ACO-27 | Diabetes: Hemoglobin A1c Poor Control (>9%) | 13.29 | 14.70 |
ACO-28 | Controlling High Blood Pressure | 70.86 | 72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
In addition, we provide an easy way to report possible misconduct. Our goal is to ensure high-quality, evidence-based, respectful care for our patients, and if you believe you’ve received less than that, we want to hear from you.
If you have questions about any of this information, please feel free to contact us.